MY KOLKATA EDUGRAPH
ADVERTISEMENT
regular-article-logo Thursday, 02 May 2024

Goyal holds review meeting on medical oxygen preparedness

Commerce and Industry minister's meet to check on supply in the event of a sudden surge of O2 amid impending third wave

Our Bureau, PTI New Delhi Published 30.12.21, 03:53 PM
Piyush Goyal

Piyush Goyal File picture

Commerce and Industry Minister Piyush Goyal on Thursday discussed with senior officials effective ways to ensure adequate medical oxygen availability in the country in the wake of increasing COVID-19 cases.

Due to an unprecedented surge in demand for medical oxygen across the country during the second wave of COVID-19, the demand peaked at nearly 9,000 MT (metric tonnes) as compared to the peak requirement of 3,095 MT during the first wave.

ADVERTISEMENT

The supply of oxygen for medical purposes was enhanced almost 10 times from 1,000 tonnes per day in December 2019 to 9,600 tonnes per day in May this year.

"Held a review meeting on the medical oxygen preparedness in the country. Deliberated on effective ways to ensure adequate medical oxygen availability for strengthening the fight against COVID-19 pandemic," Goyal said in a tweet.

India recorded the highest single-day rise of Omicron infections with 180 fresh cases, taking the total tally of such infections in the country to 961, according to the Union health ministry's data updated on Thursday.

The 961 cases have been detected across 22 states and UTs so far, and 320 people have recovered or migrated.

Delhi recorded the highest number of 263 cases, followed by Maharashtra at 252, Gujarat 97, Rajasthan 69, Kerala 65 and Telangana 62.

The daily rise in COVID-19 cases crossed the 13,000 mark after around 49 days, taking the total tally to 3,48,22,040, while the active cases increased to 82,402, according to the data updated at 8 am.

The death toll has climbed to 4,80,860 with 268 fresh fatalities, the data stated.

A total of 13,091 new coronavirus infections were reported in a span of 24 hours on November 11.

Follow us on:
ADVERTISEMENT